periodont
one
complex
infecti
diseas
human
bodi
individu
periodont
lesion
may
harbor
million
genom
copi
herpesvirus
well
papillomavirus
human
immunodefici
viru
hiv
human
tlymphotrop
viru
type
torquetenoviru
hepat
b
c
virus
herpesvirusinfect
periodont
site
tend
exhibit
breakdown
herpesvirusfre
site
herpesvir
activ
infect
associ
elev
risk
progress
periodont
diseas
furthermor
oral
caviti
support
bacteri
speci
periodont
pocket
area
harbor
bacteri
speci
periodontopath
bacteria
porphyromona
gingivali
tannerella
forsythia
possess
virul
factor
involv
colon
periodont
site
neutral
local
host
defens
destroy
periodont
tissu
host
immun
respons
attempt
control
pathogen
virus
bacteria
periodont
site
howev
unclear
variou
immun
mediat
certain
cytokin
chemokin
exert
primarili
protect
destruct
role
periodont
diseas
also
immun
mechan
activ
virus
may
diminish
antibacteri
immun
respons
vice
versa
may
periodont
result
extens
partli
oppos
immun
respons
viralbacteri
combin
infect
major
advanc
diagnosi
prevent
treatment
periodont
probabl
depend
upon
better
understand
pathogen
infect
associ
host
respons
review
articl
present
evid
virus
bacteria
aggreg
produc
greater
pathogen
effect
sum
individu
agent
discuss
concept
herpesviralbacteri
combin
infect
may
chang
understand
pathogenesi
possibl
manag
destruct
periodont
diseas
emphasi
place
synergist
interact
periodont
epsteinbarr
viru
cytomegaloviru
major
suspect
periodontopath
bacteria
respiratori
diseas
repres
bestknown
exampl
seriou
viralbacteri
coinfect
worldwid
respiratori
infect
give
rise
diseas
death
human
infect
one
lead
caus
morbid
mortal
season
influenza
usa
estim
result
hospit
death
annual
great
influenza
pandem
caus
million
death
worldwid
estim
death
usa
affect
mostli
young
adult
usual
children
old
individu
peak
half
popul
clinic
infect
influenza
pandem
year
type
influenza
subtyp
type
influenza
subtyp
incid
secondari
bacteri
pneumonia
common
caus
excess
mortal
influenza
outbreak
vari
differ
popul
influenza
swine
flu
pandem
involv
novel
strain
main
bacteria
influenzaassoci
pneumonia
streptococcu
pneumonia
alphahemolyt
streptococci
haemophilu
influenza
staphylococcu
aureu
moraxella
branhamella
catarrhali
combin
infect
influenza
virus
aureu
caus
particularli
sever
fatal
pneumonia
children
adult
respiratori
virus
influenza
virus
also
interact
pathogen
bacteri
pathogen
exampl
human
parainfluenza
viru
pneumonia
adenoviru
bordetella
pertussi
studi
communityacquir
childhood
pneumonia
reveal
mix
viralbacteri
infect
compris
pneumonia
studi
result
sever
inflamm
clinic
ill
singl
viral
bacteri
infect
virus
induc
alter
respiratori
tract
allow
resid
bacteria
multipli
level
capabl
induc
inflamm
respiratori
tract
virus
inhibit
ciliari
activ
respiratori
epithelium
therebi
increas
risk
bacteri
superinfect
respiratori
cell
infect
influenza
viru
respiratori
syncyti
virus
adenovirus
show
enhanc
bacteri
adher
vitro
vivo
model
system
influenza
viru
may
predispos
secondari
bacteri
pneumonia
denud
respiratori
epithelium
expos
basement
membran
element
eg
fibrinogen
bacteria
attach
influenza
viru
infect
also
caus
prolong
desensit
lung
sentinel
cell
tolllik
receptor
ligand
result
reduc
presenc
neutrophil
increas
secondari
bacteri
load
addit
alter
neutrophil
function
influenza
viru
may
decreas
clearanc
pulmonari
bacteria
acut
otiti
media
link
synergist
interact
virus
bacteria
otiti
media
often
associ
virus
rhinoviru
respiratori
syncyti
viru
adenoviru
coronaviru
influenza
viru
cytomegaloviru
herpesvirus
well
bacteria
includ
h
influenza
pneumonia
catarrhali
prevotella
peptostreptococcu
speci
acut
otiti
media
tympanostomi
tube
show
pneumonia
aureu
h
influenza
pseudomona
aeruginosa
yeast
virus
detect
acut
otiti
media
sampl
posit
h
influenza
sampl
posit
pneumonia
sampl
posit
catarrhali
tympan
membran
chang
acut
otiti
media
sever
patient
coinfect
respiratori
virus
bacteria
patient
singl
infect
either
two
type
infecti
agent
virus
interact
bacteria
acut
otiti
media
boost
local
inflammatori
process
also
profound
advers
effect
resolut
diseas
human
diseas
seem
also
combin
viralbacteri
etiopathogeni
recurr
bacteri
sinus
may
develop
complic
viral
cold
infecti
mononucleosi
caus
infect
epsteinbarr
viru
give
rise
tonsillar
upgrowth
prevotella
intermedia
fusobacterium
nucleatum
subsequ
pharyngotonsil
syndrom
character
sever
pharyng
sepsi
occur
sequel
epsteinbarr
virusinduc
mononucleosi
frequent
associ
overgrowth
fusobacterium
necrophorum
gastroenter
often
associ
mix
infect
virus
rotaviru
adenoviru
noroviru
astroviru
bacteria
pathogen
escherichia
coli
salmonella
shigella
campylobact
jejuni
combin
viralbacteri
infect
lead
enhanc
pathosi
append
associ
measl
viru
adenoviru
herpesvirus
well
bacteroid
fragili
e
coli
yersinia
salmonella
shigella
helicobact
pyloriassoci
gastriti
activ
latent
epsteinbarr
viru
infect
monochloramin
infiltr
neutrophil
aggrav
gastric
diseas
organ
transplant
recipi
cytomegaloviru
human
herpesvirus
type
type
induc
seriou
opportunist
infect
bacteria
fungi
protozoa
virus
probabl
result
immunomodul
herpesvirus
renal
transplant
patient
develop
subhepat
abscess
result
infect
cytomegaloviru
p
gingivali
vascular
diseas
occur
higher
frequenc
result
combin
infect
herp
simplex
viru
chlamydia
pneumonia
periodontopath
bacteria
singl
infect
either
agent
rheumat
heart
diseas
autoimmun
myocard
may
involv
dual
infect
coxsackieviru
group
streptococci
potenti
dysregul
immun
mechan
trigger
autoimmun
reaction
hiv
infect
caus
varieti
sever
bacteri
fungal
viral
infect
moreov
p
gingivali
may
upregul
express
coreceptor
oral
keratinocyt
therebi
increas
risk
oral
infect
dissemin
strain
also
variou
gramposit
gramneg
bacteria
periodont
biofilm
capac
reactiv
hiv
latent
infect
cell
macrophag
dendrit
cell
vaginosi
bacteria
prevotella
bivia
peptostreptococcu
asaccharolyticu
vagin
bacteria
studi
potenti
activ
hiv
express
monocytoid
cell
tlymphocyt
cell
anim
model
use
studi
viralbacteri
interact
respiratori
pathosi
enhanc
mice
influenza
viru
virus
coinfect
bacteria
mous
model
pathogenet
synergi
influenza
viru
infect
anteced
pneumonia
challeng
caus
pneumonia
led
mortal
wherea
infect
pneumonia
prior
influenza
viru
infect
provid
protect
influenza
improv
surviv
rate
immun
mediat
includ
cytokin
chemokin
tolllik
receptor
mitogenactiv
protein
kinas
pathway
seem
play
import
role
pathogenesi
influenza
viruss
pneumonia
coinfect
calv
dualli
infect
bovin
respiratori
syncyti
viru
haemophilu
somnu
bovin
respiratori
pathogen
contract
lung
diseas
harbor
h
somnu
lung
wherea
lung
monoinfect
calv
show
neither
pathosi
h
somnu
infect
acut
otiti
media
induc
mice
stabli
colon
pneumonia
infect
influenza
viru
wherea
mockinfect
mice
remain
free
diseas
mice
infect
herp
simplex
viru
adenoviru
vaccinia
viru
reveal
enhanc
suscept
e
coli
pyelonephr
mice
inocul
intraperiton
murin
cytomegaloviru
togeth
p
aeruginosa
aureu
candida
albican
exhibit
mortal
rate
wherea
immun
murin
cytomegaloviru
abrog
synergist
effect
mortal
combin
infecti
agent
studi
immunocompromis
rat
symptomat
infect
rat
cytomegaloviru
induc
sever
neutropenia
subsequ
high
rate
enter
gramneg
rod
bacteremia
markedli
higher
mortal
rate
found
mice
coinfect
murin
cytomegaloviru
p
gingivali
mice
monoinfect
either
cytomegaloviru
p
gingivali
significantli
lower
level
system
interferongamma
detect
dualli
infect
mice
monoinfect
mice
suggest
p
gingivali
abl
reduc
antivir
interferongamma
respons
thu
increas
pathogen
coinfect
cytomegaloviru
complet
latent
herpesviru
infect
may
experiment
set
upregul
activ
state
innat
immun
therebi
provid
immun
benefit
host
mice
latent
infect
murin
epsteinbarr
viru
cytomegaloviru
show
resist
infect
bacteri
pathogen
listeria
monocytogen
yersinia
pesti
howev
herpesvirusinduc
protect
bacteri
infect
seem
transient
last
month
collect
numer
studi
natur
diseas
experiment
infect
conclud
viralbacteri
coinfect
produc
diseas
singl
infect
either
two
type
infecti
agent
earli
studi
viralbacteri
synerg
emphas
decreas
clearanc
enhanc
pathogen
bacteria
involv
infecti
complex
recent
investig
also
point
possibl
increas
virul
viru
million
herpesvirus
bacteria
inhabit
individu
periodont
site
reason
assum
herpesviralbacteri
interact
also
play
role
develop
human
periodont
studi
variou
countri
found
genom
copi
epsteinbarr
viru
cytomegaloviru
present
periodont
lesion
less
preval
gingiv
healthi
periodont
site
tabl
studytostudi
variat
detect
periodont
herpesvirus
may
result
clinic
statu
studi
subject
ii
viral
diagnost
method
util
iii
true
geograph
ethnic
differ
herpesvir
occurr
identif
periodont
herpesvirus
influenc
sampl
site
method
util
pathogen
load
typic
peak
period
activ
diseas
herpesviru
recoveri
periodont
site
depend
greatli
accuraci
clinic
diagnosi
difficulti
defin
periodont
purpos
research
recent
point
use
patient
age
main
criterion
distinguish
periodont
may
reliabl
indic
activ
stabl
diseas
term
periodont
site
sometim
use
suggest
absenc
attach
loss
rather
inflammationfre
gingiva
herpesvirus
may
enter
even
slightli
inflam
periodont
site
sensit
polymeras
chain
reaction
pcr
techniqu
may
show
virus
control
site
convers
periodont
therapi
markedli
reduc
herpesviru
subgingiv
count
thu
caus
signific
underestim
viral
load
associ
untreat
diseas
reliabl
data
preval
quantiti
periodont
herpesvirus
may
requir
studi
virgin
lesion
welldefin
diseaseact
statu
studi
examin
small
number
periodont
site
subject
inevit
underestim
preval
herpesvirus
studi
popul
total
number
herpesviru
genomecopi
entir
periodontium
studi
herpesvirus
subgingiv
site
also
account
substanti
herpesviru
count
resid
within
inflam
gingiv
tissu
era
reli
upon
vitro
cell
cultur
routin
laboratori
diagnosi
viral
infect
truli
pass
viral
isol
indic
activ
possibl
diseaseproduc
infect
isol
virus
difficult
costli
timeconsum
highfidel
pcrbase
techniqu
becom
standard
identif
quantif
periodont
herpesvirus
transcript
late
herpesviru
gene
structur
protein
understood
signifi
product
viral
replic
commonli
use
indic
activ
herpesviru
infect
pcr
identif
oral
herp
simplex
viru
may
yield
twoto
fourfold
posit
sampl
viral
cultur
nest
pcr
may
unveil
periodont
site
posit
cytomegaloviru
viral
cultur
realtim
pcr
endpoint
detect
pcr
nest
pcr
technolog
particularli
effici
detect
low
viral
load
howev
pcr
primer
amplifi
templat
microbi
commun
differ
effici
may
yield
bias
result
misamplif
falseposit
herpesviru
result
may
emerg
share
region
nucleotid
sequenc
herpesviru
speci
unknown
infecti
agent
nevertheless
periodont
epsteinbarr
viru
cytomegaloviru
identifi
use
varieti
pcr
primer
platform
endpoint
detect
pcr
nest
pcr
revers
transcript
pcr
realtim
pcr
risk
systemat
misidentif
virus
small
howev
differ
pcr
primer
protocol
may
detect
herpesvirus
vari
degre
profici
technic
expertis
qualiti
assur
method
vari
among
laboratori
prepar
target
nucleic
acid
constitut
particularli
vulner
stage
pcr
protocol
genotyp
distribut
seropreval
epsteinbarr
viru
cytomegaloviru
differ
among
popul
similarli
medic
infect
herpesviru
subtyp
may
exhibit
increas
periodontopathogen
glycoprotein
b
gb
homologu
within
herpesviru
famili
particip
viru
entri
celltocel
spread
encod
gene
commonli
use
genotyp
cytomegaloviru
gbii
genotyp
seem
predomin
chronic
periodont
wherea
cytomegaloviru
gbi
genotyp
close
relat
gingiv
healthi
periodontium
addit
herpesvirus
occur
higher
preval
lowincom
countri
affluent
countri
herpesviru
seropreval
highincom
countri
exhibit
signific
racial
educ
socioeconom
dispar
start
earli
age
persist
middl
age
epsteinbarr
viru
cytomegaloviru
genom
identifi
periodont
lesion
preval
rang
per
cent
tabl
cytomegaloviru
seroposit
identifi
patient
periodont
patient
gingiv
p
epsteinbarr
viru
cytomegaloviru
also
common
inhabit
periap
lesion
endodont
origin
cytomegaloviru
detect
periap
abscess
exhibit
spontan
pain
assess
detail
linkag
herpesvirus
periodont
patient
group
accord
diseas
sever
tabl
reveal
presenc
epsteinbarr
viru
aggress
periodont
lesion
chronic
periodont
lesion
cytomegaloviru
aggress
periodont
lesion
chronic
periodont
lesion
although
preval
epsteinbarr
viru
cytomegaloviru
similar
aggress
chronic
periodont
herpesviru
infect
may
differ
qualit
two
diseas
activ
cytomegaloviru
infect
tend
associ
periodont
site
show
radiograph
evid
alveolar
crestal
lamina
dura
find
consist
diseaseact
periodont
activ
cytomegaloviru
infect
also
link
increas
gingiv
inflamm
immunosuppress
organtranspl
recipi
acut
herp
simplex
virustyp
infect
patient
caus
within
hour
extens
gingiv
recess
contrast
latent
herpesviru
infect
gener
associ
chronic
periodont
site
exhibit
littl
propens
diseas
progress
quantit
significantli
herpesviru
genom
copi
inhabit
progress
untreat
periodont
lesion
stabl
treat
periodont
site
mani
epsteinbarr
viru
dna
copi
cytomegaloviru
dna
copi
detect
sampl
individu
periodont
pocket
even
higher
viral
load
may
resid
within
gingiv
tissu
periodont
lesion
sund
et
al
identifi
one
million
genomecopi
epsteinbarr
viru
periodont
site
yearold
patient
refractori
periodont
herpesvirus
epsteinbarr
viru
cytomegaloviru
well
papillomaviru
virus
also
inhabit
periodont
lesion
inde
total
count
virus
approach
bacteria
advanc
periodont
lesion
abund
herpesviru
genom
copi
individu
periodont
lesion
translat
heavi
viral
load
entir
periodontium
patient
sever
widespread
periodont
diseas
high
number
herpesvir
copi
progress
periodont
implic
understand
etiolog
diseas
tabl
summar
statist
relationship
periodont
herpesvirus
bacteria
studi
china
found
epsteinbarr
virusposit
periodont
lesion
cytomegalovirusposit
periodont
lesion
contain
mani
six
eight
speci
major
periodontopath
bacteria
periodont
epsteinbarr
viru
cytomegaloviru
seem
close
associ
p
gingivali
forsythia
two
bacteria
high
periodontopath
potenti
link
cytomegaloviru
p
gingivali
appear
particularli
strong
cytomegaloviru
p
gingivali
link
local
aggress
juvenil
periodont
jamaica
odd
ratio
respect
cytomegalovirusp
gingivali
dual
infect
link
diseas
odd
ratio
high
significantli
higher
odd
ratio
cytomegalovirusp
gingivali
coinfect
sum
individu
pathogen
suggest
pathogenet
synergi
infecti
agent
studi
usa
adult
gingiv
periodont
link
epsteinbarr
cytomegaloviru
elev
occurr
pathogen
p
gingivali
forsythia
p
intermedia
prevotella
nigrescen
treponema
denticola
tabl
studi
japan
p
gingivali
compris
total
salivari
bacteri
count
epsteinbarr
virusposit
periodont
patient
differ
epsteinbarr
virusneg
patient
periodont
epsteinbarr
viru
cytomegaloviru
also
relat
subgingiv
presenc
major
periodontopathogen
aggregatibact
actinomycetemcomitan
associ
herpesvirus
anaerob
bacteria
also
demonstr
periap
pathosi
herp
simplex
viru
may
particip
periodont
diseas
subgroup
individu
herp
simplex
combin
p
gingivali
forsythia
p
intermedia
actinomycetemcomitan
link
periodont
combin
denticola
forsythia
dialist
pneumosint
periodont
necrot
dental
pulp
despit
larg
bodi
support
evid
welldesign
studi
divers
popul
still
need
corrobor
find
relationship
variou
herpesviralbacteri
consortia
periodont
diseas
sever
research
also
need
determin
extent
herpesviralbacteri
coinfect
periodont
repres
pathogenet
signific
interact
mere
independ
etiolog
import
infecti
agent
periodont
immun
respons
herpesvir
bacteri
infect
bifunct
tissu
slot
et
al
campylobact
rectu
saygun
et
al
treponema
denticola
contrera
et
al
protect
tissuedestruct
effect
depend
upon
type
infecti
agent
immun
compet
individu
featur
herpesvir
bacteri
infect
import
etiopathogeni
periodont
highlight
infecti
agent
caus
periodont
must
abl
colon
periodont
site
overcom
local
host
defens
prolifer
periodont
site
particip
breakdown
periodont
tissu
also
periodont
develop
multistep
process
reflect
dynam
interplay
periodont
infecti
agent
host
immun
respons
success
immun
control
periodont
infect
depend
highli
coordin
seri
host
defens
host
identifi
pathogen
nonself
recogn
pathogenassoci
molecular
pattern
pathogen
recognit
receptor
signal
pathway
subsequ
activ
cell
immun
system
cytokin
mediat
interact
regul
immun
cell
optim
host
execut
immun
respons
suffici
control
pathogen
also
ensur
suppress
excess
immun
reaction
order
limit
patholog
consequ
inflamm
uncoordin
host
immun
respons
may
caus
pathosi
immun
regul
mediat
activ
cell
basi
characterist
cytokin
profil
group
helper
th
type
induc
regulatori
itreg
cell
activ
helper
cell
secret
either
proor
antiinflammatori
cytokin
depend
type
mode
immunolog
stimulu
cell
drive
pathway
fight
envelop
virus
intracellular
bacteri
pathogen
elimin
cancer
cell
stimul
delayedtyp
hypersensit
reaction
activ
cell
character
proinflammatori
sourc
interferongamma
interleukin
il
tumor
necrosi
factoralpha
cytomegaloviru
herpesvirus
induc
proinflammatori
cytokin
respons
proinflammatori
cytokin
chemokin
promot
leukocyt
infiltr
site
infect
play
crucial
role
orchestr
immun
respons
herpesviru
infect
enhanc
prolifer
lymphocyt
facilit
cellcel
signal
cell
induc
pathway
link
differenti
b
cell
antibodi
product
antibodi
critic
import
defens
nonenvelop
virus
extracellular
bacteri
pathogen
respons
evok
secret
antiinflammatori
immunoregulatori
cytokin
howev
concept
inconsist
sever
human
anim
cytokin
activ
fail
fall
exclus
pattern
act
proinflammatori
antiinflammatori
cytokin
also
variou
cytokin
inflamm
uniqu
redund
role
augment
inhibit
effect
cytokin
complic
assess
biolog
signific
individu
cytokin
addit
cell
inhibit
cell
differenti
express
interferongamma
cell
inhibit
cell
express
transform
growth
factorbeta
balanc
immun
respons
regul
itreg
cell
influenc
genet
environment
factor
feedback
mechan
among
type
cytokin
aim
amplifi
dampen
local
inflammatori
respons
order
sustain
adequ
host
respons
safeguard
host
burst
exagger
inflamm
cell
respons
receiv
consider
interest
periodont
research
immun
respons
partli
antagonist
net
effect
combin
immun
respons
may
determin
whether
periodont
infect
lead
limit
gingiv
tissu
reaction
breakdown
periodont
attach
proinflammatori
cytokin
occur
elev
level
sever
periodont
lesion
exert
immunomodul
activ
well
particip
collagen
degrad
bone
resorpt
periodont
lesion
concurr
harbor
herpesvirus
trigger
cellular
immun
pathogen
bacteria
induc
humor
immun
diseas
periodontium
may
experi
chang
domin
either
herpesvir
bacteri
immun
studi
suggest
cell
associ
stabl
periodont
cell
associ
diseas
progress
studi
report
predomin
cell
reduc
respons
diseas
periodont
tissu
find
necessarili
conflict
predomin
cell
diseasest
site
may
suggest
success
antiherpesviru
defens
elev
level
cell
progress
lesion
may
reflect
ongo
effort
host
control
activ
herpesviru
infect
similarli
disput
domin
either
cell
b
cell
periodont
site
may
partli
unfound
preponder
cell
may
reflect
attempt
host
control
activ
herpesviru
infect
high
bcell
count
may
caus
specif
antibodi
product
result
activ
epsteinbarr
viru
infect
absenc
suffici
cytotox
tcell
function
induc
bcell
prolifer
polyclon
stimul
eight
human
member
herpesviru
famili
infect
parenchym
cell
connect
tissu
cell
epitheli
cell
variou
hematopoiet
cell
cell
type
caus
varieti
ill
mechan
direct
indirect
immunoregulatori
clinic
outcom
herpesviru
infect
rang
subclin
mild
diseas
enceph
pneumonia
potenti
lethal
infect
even
cancer
includ
lymphoma
sarcoma
carcinoma
great
major
adult
carrier
epsteinbarr
viru
cytomegaloviru
infect
person
harbor
herpesviru
life
herpesviru
replicationcycl
includ
bind
viral
envelop
glycoprotein
cellmembran
receptor
intern
dismantl
viru
particl
migrat
viral
dna
cell
nucleu
transcript
viral
gene
assembl
virion
viral
egress
infect
cell
fig
herpesvirus
destroy
infect
cell
activ
lytic
replic
primari
infect
herpesvirus
remain
latent
limit
express
viral
gene
albeit
retain
transcript
replic
capac
latenc
persist
maintain
epsteinbarr
viru
rest
memori
b
lymphocyt
human
cytomegaloviru
dendrit
cell
monocyt
progenitor
activ
herpesviru
infect
evok
strong
innat
adapt
immun
respons
includ
immun
activ
immun
suppress
key
effector
cell
innat
immun
system
dendrit
cell
monocyt
macrophag
natur
killer
cell
whose
function
limit
viral
burden
cell
adapt
immun
becom
avail
suppress
infect
effector
cell
recogn
viral
protein
via
tolllik
receptor
natur
killer
cell
receptor
pattern
recognit
receptor
herpesviru
dna
react
tolllik
receptor
significantli
upregul
periodont
lesion
compar
gingiv
lesion
cell
innat
immun
employ
cytokin
secret
cellmedi
cytotox
primari
antiherpesviru
effector
mechan
macrophag
polymorphonuclear
leukocyt
destroy
antibodyco
virion
virusinfect
cell
via
reactiv
oxygen
speci
nitric
oxid
activ
caspas
natur
killer
cell
import
sourc
interferongamma
abl
kill
herpesvirusinfect
cell
via
virusspecif
antibodydepend
cellmedi
cytotox
via
antibodyindepend
mechan
addit
natur
killer
cell
share
similar
cytotox
cell
may
play
role
adapt
immun
phagocyt
cell
intern
process
express
herpesvirusderiv
immunogen
peptid
surfac
linkag
major
histocompat
complex
mhc
molecul
attach
activ
cell
adapt
immun
system
cytomegaloviru
profound
influenc
immun
system
healthi
individu
cytomegaloviru
reactiv
detect
mani
cell
cytomegalovirusseroposit
elderli
individu
recognit
herpesviru
protein
caus
induct
proinflammatori
transcript
factor
nuclear
factorkappab
nfjb
subsequ
releas
cytokin
mobil
cell
activ
cell
differenti
virusspecif
cytotox
cell
capabl
recogn
kill
cell
carri
viral
peptid
releas
tcellassoci
antivir
cytokin
interferongamma
tumor
necrosi
factoralpha
may
also
inhibit
viral
replic
without
kill
infect
cell
herpesviru
infect
immunocompet
individu
also
induc
antibodi
product
herpesviru
protein
patient
periodont
exhibit
elev
level
antibodi
herpesvirus
howev
antibodi
herpesvirus
mani
envelop
virus
ensur
favor
clinic
outcom
herpesvirus
develop
strategi
downregul
antivir
host
defens
order
persist
midst
intens
inflamm
immunosuppress
may
thu
take
place
even
presenc
substanti
immun
activ
herpesvirus
encod
immunoevas
glycoprotein
interfer
antigen
present
tcell
immun
surveil
natur
killer
cell
function
viral
protein
seek
alter
mimic
mhc
protein
function
leukocyt
activ
migrat
induct
activ
cytokin
interferon
antibodybas
defens
mechan
host
cell
suscept
apoptosi
program
cell
death
princip
mode
physiolog
elimin
cell
despit
elabor
immuneevas
effort
herpesvirus
host
immun
system
gener
prevail
immunocompet
subject
perhap
host
immunesens
mechan
termin
viral
gene
express
assembl
infecti
virion
howev
herpesviru
diseas
incid
elev
immunolog
immatur
subject
individu
immunosuppress
result
advanc
age
immunosenesc
diseas
eg
hiv
acquir
immunedefici
syndrom
aid
treatment
eg
cancer
chemotherapi
radiotherapi
pharmacolog
immunosuppress
organ
transplant
highdos
corticosteroid
bacteri
infect
evok
function
innat
immun
system
adapt
immun
system
bacteri
speci
attach
specif
tolllik
receptor
establish
degre
specif
innat
immun
system
subsequ
adapt
immun
system
bacteri
pathogen
detect
tolllik
receptor
surfac
macrophag
activ
nfjbmediat
transcript
cytokin
chemokin
macrophag
releas
cytokin
chemokin
recruit
neutrophil
innat
immun
system
serv
antigenpres
cell
lymphocyt
adapt
immun
system
neutrophil
compris
inflammatori
cell
periodont
pocket
import
periodont
defens
evidenc
observ
sever
periodont
subject
exhibit
major
neutrophil
defici
neutrophil
phagocyt
kill
ingest
bacteria
mean
reactiv
oxygen
speci
eg
myeloperoxidas
system
hypochlorit
antimicrobi
protein
eg
defensin
lysozym
lactoferrin
degrad
enzym
eg
elastas
cathepsin
g
microbicid
pathway
extracellular
pathogen
bacteria
activ
cell
releas
antiinflammatori
cytokin
commit
b
cell
antibodi
product
p
gingivali
seem
evok
primarili
respons
periodont
patient
antibacteri
antibodi
subclass
play
import
role
opson
complement
activ
lipopolysaccharid
p
gingivali
periodontopath
bacteria
also
activ
complement
via
altern
pathway
induc
releas
proinflammatori
cytokin
complement
assist
antibodi
act
opsonin
lyse
bacteri
cell
attract
lymphocyt
neutrophil
site
infect
intracellular
bacteria
trigger
immun
respons
includ
releas
interferongamma
proinflammatori
cytokin
antibodi
isotyp
serum
antibodi
occur
high
level
patient
local
aggress
juvenil
periodont
despit
less
effici
opsonin
seem
protect
tissu
destruct
p
gingivali
actinomycetemcomitan
periodont
speci
abil
invad
cell
periodontium
thu
may
trigger
well
immun
respons
p
gingivalisspecif
cell
produc
cytokin
irrespect
type
antigenpres
cell
epsteinbarr
viruscytomegaloviru
coinfect
tend
associ
sever
type
oral
diseas
includ
aggress
periodont
chronic
periodont
periodont
abscess
acut
necrot
ulcer
gingiv
symptomat
periap
lesion
oral
ulcer
cytomegalovirusherp
simplex
viru
coinfect
also
associ
increas
gingiv
inflamm
periodont
attach
loss
person
exhibit
high
rate
shed
epsteinbarr
viru
saliva
tend
reveal
salivari
cytomegaloviru
dna
often
low
rate
epsteinbarr
viru
shed
may
suggest
cooper
relationship
two
virus
infant
children
infect
epsteinbarr
viru
cytomegaloviru
shown
stronger
tcell
respons
sever
diseas
children
monoinfect
either
virus
felin
caliciviru
felin
herpesviru
shed
cat
chronic
gingivostomat
compar
cat
without
chronic
oral
inflammatori
diseas
concomit
infect
two
herpesvirus
may
activ
latent
viral
genom
mechan
reciproc
transactiv
connot
gene
product
one
viru
trigger
transcript
anoth
viru
two
activ
virus
provid
uniqu
set
virul
factor
result
particularli
sever
disrupt
immun
system
acceler
diseas
process
herpesviru
reactiv
caus
major
spike
cytotox
cell
proinflammatori
cytokin
also
produc
virusderiv
homologu
human
inhibitor
antivir
cellmedi
defens
cytomegaloviru
suppress
nfjb
activ
subsequ
transcript
tumor
necrosi
factoralpha
specif
genotyp
correl
increas
risk
progress
periodont
mechan
interact
two
virus
includ
enhanc
express
viral
receptor
coreceptor
target
cell
well
product
superantigen
herpesvirus
specif
bacteria
aggreg
also
associ
enhanc
sever
periodont
diseas
herpesvirus
may
aid
initi
colon
upgrowth
periodontopath
bacteria
activ
human
cytomegaloviru
infect
primari
periodont
pocket
epitheli
cell
hela
cell
enhanc
adher
actinomycetemcomitan
dosedepend
mode
viral
infect
may
destroy
epitheli
cell
expos
new
bacteri
attach
site
basement
membran
herpesviru
glycoprotein
express
surfac
infect
host
cell
may
serv
receptor
bacteria
addit
actinomycetemcomitan
bind
fc
part
igg
molecul
organ
may
attach
antibodi
direct
herpesvirusderiv
glycoprotein
consist
concept
herpesviralbacteri
synerg
initi
phase
local
aggress
juvenil
periodont
demonstr
activ
cytomegaloviru
infect
remark
increas
actinomycetemcomitan
subgingiv
count
cytomegaloviru
sever
anim
model
shown
abil
impair
neutrophil
chemotaxi
phagocytosi
oxid
burst
intracellular
kill
capac
neutrophil
defect
also
describ
local
aggress
periodont
individu
show
absenc
herpesvir
infect
herpesvir
reactiv
may
exhibit
normal
periodontium
minim
nonprogress
diseas
even
presenc
periodontopath
bacteria
herpesvirus
compromis
immun
control
periodontopath
bacteria
varieti
mechan
polymorphonuclear
leukocyt
seem
exhibit
less
effici
chemotaxi
bactericid
capac
periodont
patient
subgingiv
herpesvirus
herpesvirusfre
subject
antiherpesviru
cytotox
suppressor
cell
present
elev
level
aggress
periodont
lesion
may
advers
affect
mammalian
cell
involv
antibacteri
periodont
defens
cytokin
associ
activ
herpesviru
infect
reduc
respons
therebi
antibodymedi
control
pathogen
bacteria
herpesvirus
capabl
subvert
macrophag
complement
neutrophil
function
import
antibacteri
host
defens
p
gingivali
exogenouslik
speci
may
primarili
control
antibodymedi
mechan
may
benefit
reduct
antibacteri
immun
outgrow
coexist
indigen
microorgan
taken
togeth
activ
herpesviru
infect
potenti
impair
antibacteri
host
defens
may
trigger
microbi
shift
toward
virul
subgingiv
microbiota
lipopolysaccharid
gramneg
periodontopath
bacteria
promin
p
gingivali
induc
type
releas
proinflammatori
cytokin
may
cooper
cytomegaloviru
stimul
gene
transcript
cell
activ
inhibit
antibacteri
immun
lipopolysaccharideinduc
cell
respons
may
partli
constitut
immuneevas
maneuv
periodontopath
bacteria
effort
surviv
hostil
environ
hand
immun
respons
may
help
control
p
gingivali
infect
occur
intracellularli
also
herpesvirus
may
induc
overgrowth
p
gingivali
pathogen
speci
antiherpesviru
immun
respons
may
indirectli
aid
contain
popul
periodontopath
bacteria
equal
conceiv
bacteri
infect
pave
way
herpesviru
clinic
infect
p
gingivali
sonic
potenti
reactiv
epsteinbarr
viru
etiopathogen
model
periodont
detail
propos
bacterialviralbacteri
sequenti
infect
give
rise
diseas
dental
biofilm
bacteria
initi
gingiv
influx
herpesvirusinfect
monocyt
macrophag
cell
b
cell
subsequ
immunosuppress
event
may
reactiv
latent
herpesvirus
result
releas
proinflammatori
cytokin
matrix
metalloproteinas
overgrowth
periodontopath
bacteria
proteolyt
enzym
periodont
bacteria
degrad
proinflammatori
cytokin
hostdefens
system
therebi
potenti
activ
coexist
latent
herpesviru
infect
human
gingiv
epitheli
cell
challeng
p
gingivali
show
fourfold
increas
primari
cytokin
level
relat
secondari
cytokin
virtual
undetect
result
direct
degrad
p
gingivali
proteas
lysin
gingipain
effect
thu
addit
subvert
host
defens
bacteri
infect
gingipain
may
exert
periodontopathogen
perturb
cytokinemedi
antivir
host
respons
lastli
herpesvirus
bacteria
may
interact
bidirect
shown
studi
infect
wound
chamber
mice
ad
anoth
level
complex
analysi
pathophysiolog
periodont
mice
coinfect
murin
cytomegaloviru
p
gingivali
wound
chamber
exhibit
significantli
higher
mortal
mice
infect
either
murin
cytomegaloviru
p
gingivali
simultan
murin
cytomegaloviru
e
coli
increas
cytomegaloviru
pathogen
relat
abil
p
gingivali
suppress
interferongamma
perhap
proteolyt
activ
organ
low
level
interferongamma
found
despit
capac
cytomegaloviru
trigger
induct
interferongamma
despit
abil
bacteri
lipopolysaccharid
via
cytokin
simul
induc
interferonproduc
cell
ad
complex
cytomegaloviru
encod
gene
capabl
inhibit
interferon
respons
antivir
process
teleolog
term
periodont
perhap
view
byproduct
effort
host
control
periodont
herpesviru
infect
avoid
system
viral
diseas
periodont
proinflammatori
cytokin
spite
capabl
induc
collagen
degrad
alveolar
bone
resorpt
may
actual
overal
benefici
help
prevent
activ
system
dissemin
virul
virus
similarli
although
cell
may
imped
antibacteri
defens
also
confer
critic
antivir
function
periodont
may
repres
excel
exampl
host
immun
respons
exert
simultan
protect
destruct
function
find
abund
herpesvirus
periodont
lesion
redefin
pathogen
paradigm
diseas
fig
describ
model
develop
periodont
core
sequenti
infecti
process
proce
bacteria
herpesviru
bacteria
initi
bacteria
dental
biofilm
induc
gingiv
permit
latent
herpesvirus
embed
dna
macrophag
lymphocyt
b
lymphocyt
infiltr
periodontium
cytomegaloviru
replic
gingiv
tissu
may
help
sustain
periodont
infect
reactiv
latent
herpesvirus
may
occur
spontan
period
decreas
host
defens
result
druginduc
immunosuppress
concurr
infect
unusu
prolong
emot
stress
hormon
chang
physic
trauma
etc
probabl
coincident
herpesvirusactiv
factor
also
suspect
risk
factor
indic
periodont
respons
activ
herpesviru
infect
host
elicit
robust
tcellmedi
immun
respons
compris
primarili
cell
counteract
hostil
host
environ
herpesvirus
turn
execut
strategi
downregul
antivir
host
defens
herpesvirus
evad
immun
respons
disintegr
compon
mhc
interf
antigen
present
silenc
natur
killer
cell
express
viral
homolog
divert
potent
cytokin
respons
inhibit
apoptosi
encount
antivir
host
defens
viral
mediat
antihost
respons
result
major
releas
proinflammatori
cytokin
potenti
activ
osteoclast
impair
antibodymedi
host
defens
exogenouslik
bacteri
speci
p
gingivali
actinomycetemcomitan
ensu
increas
pathogen
bacteria
provid
addit
mechan
periodont
tissu
destruct
cytomegaloviru
herpesvirus
exert
acut
cytopathogen
effect
fibroblast
epitheli
cell
keratinocyt
endotheli
cell
inflammatori
cell
bone
cell
activ
herpesvir
infect
sever
immunocompromis
patient
may
directli
destroy
periodont
cell
tissu
cytotox
mechan
seen
patient
necrot
ulcer
gingiv
noma
herpesviru
infect
may
particip
oral
collagen
degrad
suggest
vivo
vitro
studi
potenti
interfer
periodont
tissu
turnov
heal
herpesviru
infect
also
relat
diminish
repair
periodont
guid
tissu
regener
dri
socket
format
tooth
extract
herpesviralbacteri
model
periodont
herpesvirusrel
cytopathogen
effect
immun
evas
immunopathogen
latenc
reactiv
latenc
tissu
site
tropism
compris
import
aspect
periodont
pathosi
like
decreas
posttreat
herpesviru
count
probabl
caus
reduct
gingiv
thu
number
viral
infect
inflammatori
cell
similarli
low
herpesviru
count
healthi
periodont
site
may
result
virtual
absenc
infect
inflammatori
cell
cytomegaloviru
also
detect
healthi
periimpl
site
saliva
contain
high
genomecopi
count
herpesvirus
medic
healthi
person
shown
contain
copi
ml
epsteinbarr
viru
saliva
per
lg
dna
salivari
cytomegaloviru
dna
detect
onehalf
periodont
patient
level
copi
ml
wherea
viru
detect
saliva
periodont
normal
individu
complet
dentur
wearer
affirm
close
relationship
cytomegaloviru
periodont
occur
saliva
preval
exceed
concentr
sever
million
genomecopi
detect
whole
saliva
healthi
volunt
brazil
reach
salivari
load
genomecopi
ml
renal
allograft
recipi
hivinfect
individu
harbor
higher
salivari
cytomegaloviru
count
nonhivinfect
person
hivinfect
individu
receiv
antiretrovir
therapi
demonstr
higher
salivari
preval
copi
count
epsteinbarr
viru
herpesvirus
normal
control
subject
hivinfect
individu
reveal
salivari
median
copi
count
ml
epsteinbarr
viru
ml
cytomegaloviru
convent
periodont
treatment
reduc
salivari
epsteinbarr
viru
genomecopi
count
salivari
cytomegaloviru
copi
count
salivari
epsteinbarr
viru
count
two
children
kostmann
syndrom
averag
epsteinbarr
viru
count
per
ml
saliva
six
studi
patient
salivari
epsteinbarr
viru
prepretreat
show
viru
posttreat
sever
patient
studi
exhibit
gingiv
inflamm
posttreat
efficaci
antiging
measur
may
decreas
salivari
herpesviru
count
even
treatment
data
suggest
diseas
periodont
site
import
sourc
salivari
herpesvirus
potenti
periodont
therapi
decreas
herpesviru
level
saliva
may
reduc
risk
herpesviru
transmiss
herpesvirusrel
diseas
among
close
acquaint
herpesviralbacteri
model
periodont
provid
rational
consid
new
approach
diseas
prevent
treatment
sund
et
al
treat
patient
exhibit
refractori
periodont
high
epsteinbarr
viru
subgingiv
copi
count
antiherpesviru
drug
valacyclovir
hcl
mg
twice
day
day
treatment
suppress
subgingiv
epsteinbarr
viru
undetect
level
least
year
result
clinic
improv
sund
et
al
propos
employ
viru
screen
periodont
treatment
determin
antivir
intervent
appropri
succeed
periodont
virus
may
identifi
success
use
diagnost
dna
microarray
abl
detect
simultan
herp
simplex
viru
type
epsteinbarr
viru
cytomegaloviru
well
virus
use
multiplex
realtim
pcr
techniqu
quantifi
simultan
number
genomecopi
herp
simplex
viru
varicellazost
viru
epsteinbarr
viru
cytomegaloviru
human
newer
metagenom
pyrosequenc
techniqu
may
even
profici
identifi
known
unknown
periodont
virus
antiherpesviru
chemotherapi
also
decreas
salivari
viral
load
short
cours
valacyclovir
g
twice
day
treatment
g
twice
follow
day
result
signific
decreas
salivari
occurr
epsteinbarr
viru
compar
control
valacyclovir
mg
oral
twice
daili
month
given
elit
male
distanc
runner
reduc
salivari
load
epsteinbarr
viru
compar
placebo
valacyclovir
therapi
g
per
day
day
result
reduct
epsteinbarr
viru
genomecopi
oral
wash
fluid
patient
acut
infecti
mononucleosi
chemotherapeut
effect
virus
lytic
phase
virus
latent
phase
limit
potenti
use
diseaseact
infect
acyclovir
type
drug
acycl
nucleosid
analogu
inhibit
herpesvir
dna
polymeras
replic
viral
genom
oral
administ
acyclovir
prodrug
valacyclovir
reach
serum
concentr
similar
intraven
administ
acyclovir
prescrib
varieti
herpesvir
diseas
prolong
treatment
valacyclovir
dosag
mg
day
well
toler
perhap
except
immunosuppress
individu
advers
event
infrequ
gener
mild
headach
report
often
date
resist
valacyclovir
clinic
signific
howev
random
control
trial
need
antiherpesvir
chemotherapi
consid
standard
clinic
practic
treatment
advanc
periodont
futur
manag
periodont
diseas
may
benefit
antiherpesvir
immunotherapeut
either
prophylact
vaccin
har
immun
system
healthi
subject
prevent
infect
diseasecaus
virus
therapeut
vaccin
stimul
immun
system
combat
exist
virus
diseas
efficaci
vaccin
herpesvirus
may
also
provid
clinic
proofofprincipl
periodontopath
import
virus
notion
herpesviralbacteri
synerg
periodont
impli
vaccin
herpesvirus
also
contribut
control
periodontopath
bacteria
one
difficulti
overcom
prophylact
vaccin
declin
immun
time
carri
increas
risk
delayedonset
primari
herpesviru
diseas
increas
morbid
us
institut
medicin
assign
high
prioriti
develop
vaccin
herp
simplex
viru
epsteinbarr
viru
cytomegaloviru
given
children
etiopathogenesi
periodont
includ
virul
factor
herpesvirus
bacteria
host
immun
respons
viral
bacteri
infect
manipul
hostcel
process
infecti
agent
herpesvirus
may
induc
periodont
activ
specif
tissuedestroy
pathway
immun
system
predispos
individu
bacteri
carriag
increas
bacteri
load
howev
molecular
contribut
herpesvirus
versu
bacteria
periodont
pathosi
remain
littl
understood
inflam
periodontium
appear
major
site
epsteinbarr
viru
cytomegaloviru
accumul
reactiv
especi
progress
phase
periodont
diseas
singl
advanc
periodont
lesion
may
contain
million
genom
copi
herpesvirus
approach
total
viabl
count
bacteria
immunosuppress
factor
potenti
trigger
herpesviru
reactiv
perhap
reason
also
major
risk
factor
periodont
activ
herpesviru
infect
periodontium
may
give
rise
system
viremia
magnitud
durat
unknown
activ
herpesviru
infect
correl
periodont
diseas
activ
may
major
contributor
periodont
immun
respons
herpesvirus
potent
induc
proinflammatori
cytokin
potenti
activ
osteoclast
matrix
metalloproteinas
activ
herpesviru
infect
also
impair
antibacteri
immun
mechan
potenti
caus
upgrowth
periodontopath
bacteria
periodontopath
bacteria
may
reactiv
latent
herpesviru
infect
synerg
among
herpesvirus
bacteria
may
play
import
role
onset
progress
periodont
interplay
herpesvirus
bacteria
periodont
may
compar
marionett
theater
puppet
viru
puppet
bacteria
even
puppet
viru
control
perform
diseas
puppet
puppet
necessari
marionett
theater
function
obvious
difficult
link
herpesviru
infect
occur
childhood
periodont
debut
sever
decad
later
import
question
whether
herpesvirusperiodont
associ
etiolog
base
mere
epiphenomenon
gingiv
inflamm
studi
herpesvir
etiolog
medic
diseas
face
similar
difficulti
delin
caus
effect
distinguish
causal
correl
inform
need
extent
activ
herpesviru
infect
give
rise
destruct
periodont
diseas
extent
diseaseact
periodont
may
activ
latent
herpesviru
infect
causal
relationship
may
infer
remov
herpesvirus
specif
antivir
medic
arrest
revers
prevent
periodont
studi
assess
tempor
histolog
correl
may
also
help
elucid
role
herpesvirus
periodont
diseas
studi
may
take
advantag
molecular
techniqu
abl
quantifi
herpesviru
load
relat
either
activ
latent
herpesviru
infect
periodontitisdiseas
activ
howev
definit
answer
periodontopath
signific
herpesvirus
probabl
await
develop
efficaci
antiherpesviru
vaccin
notion
herpesviralbacteri
coinfect
periodont
may
turn
pathogenet
rosetta
stone
unlock
mani
intricaci
diseas
herpesvirusinduc
periodont
impli
antiherpesviru
immun
constitut
import
aspect
achiev
longlast
state
stabl
periodont
condit
develop
herpesviru
vaccin
distant
futur
make
topic
periodontopath
herpesvirus
particularli
intrigu
control
herpesvirus
vaccin
may
foreshadow
futur
diminish
role
tradit
periodont
therapi
surgeri
antibiot
hope
issu
rais
review
help
steer
periodont
research
new
fertil
field
investig
